▶ 調査レポート

女性用健康&美容サプリメントのグローバル市場(~2027):植物、酵素、ミネラル、オメガ3、プロバイオティクス

• 英文タイトル:Women Health & Beauty Supplements Market Research Report by Product, Consumer Group, Sales Channel, Age Group, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Women Health & Beauty Supplements Market Research Report by Product, Consumer Group, Sales Channel, Age Group, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「女性用健康&美容サプリメントのグローバル市場(~2027):植物、酵素、ミネラル、オメガ3、プロバイオティクス」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2305C003
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、237ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:食品
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社は、世界の女性用健康&美容サプリメント市場規模が2021年に551.1億ドル、2022年に600.8億ドルとなり、更に年平均9.19%成長して2027年には934.1億ドルに達すると予測しています。当市場調査レポートでは、女性用健康&美容サプリメントの世界市場を総合的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別分析(植物、酵素、ミネラル、オメガ3、プロバイオティクス)、消費者グループ別分析(閉経周辺期、PMS、閉経後、出産後、出産前)、販売チャネル別分析(直接販売、オンライン、薬局/ドラッグストア)、年齢層別分析(70歳以上、15~30歳、31~50歳、51~70歳)、地域別分析(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)、競争状況、企業情報などの内容を掲載しています。なお、当書には、Amway Corp.、Asahi Group Holdings, Ltd.、Bayer AG、Blackmores Limited、DuPont de Nemours, Inc.、Fairhaven Health, LLC、Fancl Corporation、GNC Holdings, Inc.、Grape King Bio Ltd.、Herbalife Nutrition Ltd.、Nestlé S.Aなどの企業情報が含まれています。

・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の女性用健康&美容サプリメント市場規模:製品別
- 植物の市場規模
- 酵素の市場規模
- ミネラルの市場規模
- オメガ3の市場規模
- プロバイオティクスの市場規模
・世界の女性用健康&美容サプリメント市場規模:消費者グループ別
- 閉経周辺期における市場規模
- PMSにおける市場規模
- 閉経後における市場規模
- 出産後における市場規模
- 出産前における市場規模
・世界の女性用健康&美容サプリメント市場規模:販売チャネル別
- 直接販売チャネルの市場規模
- オンラインチャネルの市場規模
- 薬局/ドラッグストアチャネルの市場規模
・世界の女性用健康&美容サプリメント市場規模:年齢層別
- 70歳以上女性における市場規模
- 15~30歳女性における市場規模
- 31~50歳女性における市場規模
- 51~70歳女性における市場規模
・世界の女性用健康&美容サプリメント市場規模:地域別
- 南北アメリカの女性用健康&美容サプリメント市場規模
アメリカの女性用健康&美容サプリメント市場規模
カナダの女性用健康&美容サプリメント市場規模
ブラジルの女性用健康&美容サプリメント市場規模
...
- アジア太平洋の女性用健康&美容サプリメント市場規模
日本の女性用健康&美容サプリメント市場規模
中国の女性用健康&美容サプリメント市場規模
インドの女性用健康&美容サプリメント市場規模
韓国の女性用健康&美容サプリメント市場規模
台湾の女性用健康&美容サプリメント市場規模
...
- ヨーロッパ/中東/アフリカの女性用健康&美容サプリメント市場規模
イギリスの女性用健康&美容サプリメント市場規模
ドイツの女性用健康&美容サプリメント市場規模
フランスの女性用健康&美容サプリメント市場規模
ロシアの女性用健康&美容サプリメント市場規模
...
- その他地域の女性用健康&美容サプリメント市場規模
・競争状況
・企業情報

The Global Women Health & Beauty Supplements Market size was estimated at USD 55.11 billion in 2021 and expected to reach USD 60.08 billion in 2022, and is projected to grow at a CAGR 9.19% to reach USD 93.41 billion by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Women Health & Beauty Supplements to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Botanicals, Enzymes, Minerals, Omega-3, Probiotics, Proteins, and Vitamins.

Based on Consumer Group, the market was studied across Perimenopause, PMS, Postmenopause, Postnatal, and Prenatal.

Based on Sales Channel, the market was studied across Direct Sales, Online, and Pharmacies/ Drug Stores.

Based on Age Group, the market was studied across Above 70 Years, Age 15-30, Age 31-50, and Age 51-70.

Based on Application, the market was studied across Beauty and Women’s Health. The Beauty is further studied across Hair Care, Nail Care, and Skin Care.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Women Health & Beauty Supplements market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Women Health & Beauty Supplements Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Women Health & Beauty Supplements Market, including Amway Corp., Asahi Group Holdings, Ltd., Bayer AG, Blackmores Limited, DuPont de Nemours, Inc., Fairhaven Health, LLC, Fancl Corporation, GNC Holdings, Inc., Grape King Bio Ltd., Herbalife Nutrition Ltd., Nestlé S.A, Nu Skin Enterprises, Inc., Pfizer, Inc., Pharmavite LLC, Suntory Holdings Limited, Swisse Wellness Pty Ltd., Taisho Pharmaceutical Co., Ltd., The Himalaya Drug Company, The Nature’s Bounty Co., Usana Health Sciences, Inc., and Vita Life Sciences Ltd..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Women Health & Beauty Supplements Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Women Health & Beauty Supplements Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Women Health & Beauty Supplements Market?
4. What is the competitive strategic window for opportunities in the Global Women Health & Beauty Supplements Market?
5. What are the technology trends and regulatory frameworks in the Global Women Health & Beauty Supplements Market?
6. What is the market share of the leading vendors in the Global Women Health & Beauty Supplements Market?
7. What modes and strategic moves are considered suitable for entering the Global Women Health & Beauty Supplements Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Cases of Hormonal Imbalances and Other Health Disorders in Women
5.1.1.2. Poor Dietary Health Habits and Sedentary Lifestyle
5.1.1.3. High Consumption of Probiotics and Multivitamins
5.1.2. Restraints
5.1.2.1. Side Effects Associated with the Health & Beauty Supplements
5.1.3. Opportunities
5.1.3.1. Inclination Towards the Natural and Plant Based Health & Beauty Supplements
5.1.3.2. Rising Trend of Superfood for Women
5.1.3.3. Increasing Literate, Working Women Population Coupled with Rising Awareness & Expenditure for Health & Beauty
5.1.4. Challenges
5.1.4.1. Authentic Source of Raw Materials and Purity of the Compound
5.2. Cumulative Impact of COVID-19

6. Women Health & Beauty Supplements Market, by Product
6.1. Introduction
6.2. Botanicals
6.3. Enzymes
6.4. Minerals
6.5. Omega-3
6.6. Probiotics
6.7. Proteins
6.8. Vitamins

7. Women Health & Beauty Supplements Market, by Consumer Group
7.1. Introduction
7.2. Perimenopause
7.3. PMS
7.4. Postmenopause
7.5. Postnatal
7.6. Prenatal

8. Women Health & Beauty Supplements Market, by Sales Channel
8.1. Introduction
8.2. Direct Sales
8.3. Online
8.4. Pharmacies/ Drug Stores

9. Women Health & Beauty Supplements Market, by Age Group
9.1. Introduction
9.2. Above 70 Years
9.3. Age 15-30
9.4. Age 31-50
9.5. Age 51-70

10. Women Health & Beauty Supplements Market, by Application
10.1. Introduction
10.2. Beauty
10.3.1. Hair Care
10.3.2. Nail Care
10.3.3. Skin Care
10.3. Women’s Health

11. Americas Women Health & Beauty Supplements Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Women Health & Beauty Supplements Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Women Health & Beauty Supplements Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion

15. Company Usability Profiles
15.1. Amway Corp.
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Asahi Group Holdings, Ltd.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Bayer AG
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Blackmores Limited
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. DuPont de Nemours, Inc.
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Fairhaven Health, LLC
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Fancl Corporation
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. GNC Holdings, Inc.
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Grape King Bio Ltd.
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Herbalife Nutrition Ltd.
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Nestlé S.A
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Nu Skin Enterprises, Inc.
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Pfizer, Inc.
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Pharmavite LLC
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Suntory Holdings Limited
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Swisse Wellness Pty Ltd.
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Taisho Pharmaceutical Co., Ltd.
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. The Himalaya Drug Company
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. The Nature’s Bounty Co.
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Usana Health Sciences, Inc.
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
15.21. Vita Life Sciences Ltd.
15.21.1. Business Overview
15.21.2. Key Executives
15.21.3. Product & Services

16. Appendix
16.1. Discussion Guide
16.2. License & Pricing